Global Gene Therapy Market to Surge to USD 36.55 Billion by 2032 | MarketsandMarkets™ [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
The global gene therapy market , valued at US$7.21 billion in 2023, stood at US$8.85 billion in 2024 and is projected to advance at a resilient CAGR of 19.4% from 2025 to 2032, culminating in a forecasted valuation of US$36.55 billion by the end of the period. This advancement underscores the increasing demand for curative and precision-based therapies addressing genetic disorders, rare diseases, and specific cancer types, alongside a strong surge in clinical research investments and technology breakthroughs. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=122857962 A Transformational Market Driven by Demand for Curative Solutions What is driving this growth? The industry is witnessing unprecedented momentum as biotechnology companies, pharmaceutical leaders, and research institutions race to deliver long-term disease modification and one-time treatment cures. Approximately 19 new gene therapy products are expected to launch between 2026 and 2032,
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pfizer (NYSE:PFE) had its price target lowered by analysts at Bank of America Corporation from $29.00 to $28.00. They now have a "neutral" rating on the stock.MarketBeat
- Pfizer declares $0.43 dividend [Seeking Alpha]Seeking Alpha
- Pfizer Declares First-Quarter 2026 DividendBusiness Wire
- Pfizer (NYSE:PFE) was given a new $28.00 price target on by analysts at Morgan Stanley.MarketBeat
- FDA intends to put its most serious warning on Covid vaccines, sources say [CNN]CNN
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/2/25 - Form 4
- 11/21/25 - Form 8-K
- 11/20/25 - Form 424B5
- PFE's page on the SEC website